RenovaCare chairman ponies up nearly $16m for wound-healing stem cell SkinGun

RenovaCare (Scottsdale, Ariz.) has announced an equity financing for $15.5 million from Kalen Capital Corporation, the family office of Harmel Rayat, who is the majority shareholder and chairman of RenovaCare. The equity financing increases his family office’s total equity investment in RenovaCare to over $20 million. “Our long-term investment in RenovaCare speaks to our conviction that patients worldwide urgently need and deserve our regenerative SkinGun therapy, which sprays a patient’s own stem cells for rapid self-healing,” Rayat said in a press release. “I’m more confident than ever in our mission to replace painful and costly skin grafting surgeries with an ultra-gentle healing mist of one’s own skin cells. I believe we are in the right place, at the right time and with the right technology.” The investment round allows the company to move forward in the regulatory approval process and clinical trial program. Rayat’s previous investment rounds allowed for pre-clinical development, product engineering and intellectual property filings. Get the full story on our sister site, Medical Design & Outsourcing. The post RenovaCare chairman ponies up nearly $16m for wound-healing stem cell SkinGun appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Regenerative Medicine Stem Cells RenovaCare Source Type: news